Innovative muscle patches derived from stem cells demonstrate efficacy in heart repair, improving function in primates and a ...

Scientists have taken a major step forward in developing a new treatment for heart failure. A recent study tested a heart ...

Novartis AG (NYSE:NVS) shares are trading higher in the premarket session on Friday. The Swiss pharma giant reported ...

Researchers from the Nagoya University Graduate School of Medicine identified an enzyme, alpha-kinase 2 (ALPK2) that is ...

Study of more than 14,000 people from Minneapolis and three other U.S. sites transcended five decades in its search for heart ...

Pharma giant Novartis comfortably beat market forecasts with its fourth-quarter results on Friday, with the Swiss firm ...

USA: The recent RELIEVE-HF trial has revealed the efficacy of transcatheter interatrial shunt implantation as a treatment for ...

Novartis’ (NOVN: VX) results show the firm humming along nicely in 2024, with sales driven by continued strong performance ...

A German medical team has developed and tested a possible treatment for people with severe heart failure that could ...

The following is a summary of “Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) ...

CNN wellness expert Dr. Leana Wen suggests what to do to reduce your risk of catching respiratory viruses this winter and how to treat them if you’re sick.